TheDose

Ammonium Polyacryloyldimethyl Taurate

Also known as Ammonium polyacryloyldimethyl taurate, APDT, Ammonium polyacryloyldimethyltaurate, Hostacerin AMPS

CIR

Safe

CIR Expert Panel says: safe as used in cosmetics.”

Ammonium Polyacryloyldimethyl Taurate is a homopolymer of the acryloyldimethyltaurate monomer (where the counterion is ammonium), used as a rheology modifier, viscosity controller, and emulsion stabilizer in cosmetic products including serums and sunscreens. The Cosmetic Ingredient Review Expert Panel assessed the safety of 21 acryloyldimethyltaurate polymers as a group in a Final Report finalized April 2017, concluding that these ingredients are safe in cosmetics in the present practices of use and concentration described in that safety assessment. The CIR panel expressed concern about residual impurities including acrylamide and methacrylamidolauric acid monomers and stressed that cGMPs should be applied to limit such impurities. No ingredient-specific PubMed literature was identified for this homopolymer by name.


Effective rheology modifier and viscosity-builder for aqueous cosmetic systems including serums and sunscreens

CIR Expert Panel found the acryloyldimethyltaurate polymer class safe with no concentration limits under normal use conditions (Final Report 4/2017)

High molecular weight synthetic polymer; not expected to penetrate intact skin


Concerns
  • · Potential residual acrylamide monomer impurity from polymerization synthesis — CIR assessment addressed class-level impurity concerns and recommended cGMP limits

CIR Expert Panel
Approved
[1]
CIR Expert Panel · Sep 1, 2022Live

CIR Quick Reference Table (September 2022) — Ammonium Polyacryloyldimethyl Taurate row: Finding=S, Citation=Final Report 4/2017 Available…

Ammonium Polyacryloyldimethyl Taurate | S | | Final Report 4/2017 Available from CIRQuickReferenceTable_AllConclusionTypes.pdf, p. 32
Verificationpdf_textView source
Sources
1
PubMed citations
0
Evidence quality
limited
Last verified
Re-reviewed when a new CIR / SCCS opinion publishes.